Share Prices & Company Research

Stockbroking

Biotech Growth Trust Plc/The

Current Price 962.00p Bid 984.00p Ask 1058.00p Change 0.00%
Last Updated: 15/06/2024 23:24. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index

Financial Highlights Year Ended 31/03/2024

Revenue
£n/am
Operating Profit/Loss
£0.31m
Dividend yield (%)
n/a
Total dividend for year
n/ap
Dividend cover
n/a
P/E Ratio
3293.30

Key Personnel

Mr Steven Andrew Ralph Bates
Director
Dr Nicola Shepherd
Independent Non-Executive Director
Mr Hamish Baillie
Independent Non-Executive Director
Mr Lord David Willetts
Independent Non-Executive Director
Mr Roger Yates
Independent Non-Executive Director
Mrs Julia Le Blan
Independent Non-Executive Director
Mr Geoffrey C Hsu
Non-Executive Director

Stock Details

EPIC
BIOGL
ISIN
GB0000385517
Shares in Issue
60.55m
Market cap
£582.49m

Analyst Views (0)

Strong Buy
 
0%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
962.00p
Bid Price
984.00p
Ask Price
1,058.00p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
962.00p
Previous Close
962.00p
Intraday High
962.00p
Intraday Low
962.00p
52 Week High
1,038.00p
52 Week Low
724.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

News

Income Statement

Year End Date
31 Mar 2024
31 Mar 2023
 
£ (M)
£ (M)
Continuing Operations
Revenue
n/a
n/a
Operating Profit/Loss
0.31
-0.56
Net Interest
-0.06
-0.04
Pre-Tax Profit
0.25
-0.60
Profit After Tax from continuing operations
0.09
-0.65
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
n/a
n/a
Attributable to:
Equity Holders of Parent Company
n/a
n/a
Minority Interests
n/a
n/a
Total Dividend Paid
n/ap
n/ap
Retained Profit/(Loss) for the Financial Year
-0.09
-0.65

Earnings per Share

Year End Date
31 Mar 2024
31 Mar 2023
Basic
0.30p
-1.60p
Diluted
0.30p
-1.60p
Adjusted
0.30p
-1.60p
Dividend per Share
n/ap
n/ap

Assets

Year End Date
31 Mar 2024
31 Mar 2023
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
n/a
n/a
Intangible Assets
n/a
n/a
Investment Properties
n/a
n/a
Investments
n/a
n/a
Other Financial Assets
n/a
n/a
Other Non-Current Assets
n/a
n/a
Current Assets
Inventories
n/a
n/a
Trade & Other Receivables
n/a
n/a
Cash at Bank & In Hand
2.13
2.77
Current Asset Investments
n/a
n/a
Other Current Assets
n/a
n/a
Other Assets
n/a
n/a
Total Assets
411.42
360.51

Liabilities

Year End Date
31 Mar 2024
31 Mar 2023
 
£ (M)
£ (M)
Current Liabilities
Borrowings
n/a
n/a
Other Current Liabilities
n/a
n/a
Total Current Liabilities
n/a
n/a
Non-Current Liabilities
Borrowings
n/a
n/a
Provisions
n/a
n/a
Other Non-Current Liabilities
n/a
n/a
Total Non-Current Liabilities
n/a
n/a
Other Liabilities
n/a
n/a
Total Liabilities
50.11
30.22

Net Assets

Year End Date
31 Mar 2024
31 Mar 2023
 
£ (M)
£ (M)
Net Assets
361.31
330.29

Capital & Reserves

Year End Date
31 Mar 2024
31 Mar 2023
 
£ (M)
£ (M)
Share Capital
n/a
n/a
Share Premium Account
79.95
79.95
Other Reserves
273.95
241.71
Retained Earnings
n/a
n/a
Shareholders Funds
361.31
330.29
Minority Interests/Other Equity
n/a
n/a
Total Equity
n/a
n/a

Dividend History

Dividend Metrics

Year End Date
31 Mar 2024
31 Mar 2023
Dividend growth
n/a%
n/a%
Dividend yield
n/a%
n/a%
Dividend cover
n/a
n/a


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.